C11orf80 Activators
C11orf80 exploit various signaling pathways to modulate the activity of this protein. Forskolin, acting directly on adenylyl cyclase, raises intracellular cAMP levels, a secondary messenger known to activate protein kinase A (PKA). The activation of PKA can lead to the phosphorylation of several proteins, including C11orf80 if it is a PKA substrate. Similarly, IBMX, by inhibiting phosphodiesterases, prevents the degradation of cAMP, maintaining an elevated concentration of this messenger molecule within the cell, which sustains PKA activity and may thus contribute to the phosphorylation state of C11orf80. Dibutyryl-cAMP, a synthetic analog of cAMP that is membrane-permeable, directly stimulates cAMP-dependent pathways and, like Forskolin and IBMX, can activate PKA, which in turn can target C11orf80. Epinephrine and glucagon, through their respective receptors, also elevate cAMP levels, again implicating the PKA pathway in the activation of C11orf80.
C11orf80 can also be influenced by other signaling molecules that modulate different kinases and pathways. PMA activates protein kinase C (PKC), which phosphorylates a wide range of cellular targets. If C11orf80 is among those targets, PMA can be instrumental in its activation. Anisomycin, by triggering the MAPK pathway, specifically the JNK arm, may lead to the activation of C11orf80 if it is sensitive to MAPK-mediated phosphorylation. Intracellular calcium plays a pivotal role in cellular signaling, and agents like Ionomycin and A23187 function as ionophores to raise intracellular calcium levels. This increase can activate calcium-dependent kinases that could potentially phosphorylate C11orf80. Thapsigargin, by inhibiting SERCA, causes a similar rise in cytosolic calcium, which may also result in the activation of kinases capable of targeting C11orf80. Bradykinin, through its receptor-mediated activation of phospholipase C, generates second messengers that lead to the activation of PKC and the release of calcium from intracellular stores, creating another pathway for the activation of C11orf80. Lastly, histamine, through its action on the H1 receptor and subsequent activation of phospholipase C, may contribute to the activation of C11orf80 via PKC-dependent mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, preventing the breakdown of cAMP and cGMP. This results in increased cAMP and cGMP levels, potentially enhancing PKA or PKG pathway signaling, which could lead to the activation of C11orf80 if it is regulated by these pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC). If C11orf80 is downstream of PKC-mediated signaling, PMA-induced PKC activation could lead to phosphorylation and activation of C11orf80. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates MAPK pathways by acting as a JNK activator. If C11orf80 is a substrate or is regulated by MAPK pathway members, anisomycin-induced MAPK pathway activation could lead to the activation of C11orf80. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that elevates intracellular calcium levels. Increased calcium may activate calcium-dependent kinases, such as calmodulin-dependent kinase, which might lead to the activation of C11orf80 if it is regulated by calcium signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels. Elevated calcium could activate kinases that phosphorylate and activate C11orf80 if it is calcium-regulated. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin acts through its receptors to activate phospholipase C, which catalyzes the production of inositol trisphosphate (IP3) and diacylglycerol (DAG), leading to increased calcium and PKC activation, respectively. If C11orf80 is regulated by these pathways, it could result in its activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore which increases intracellular calcium, potentially activating calcium-sensitive signaling pathways that could lead to the activation of C11orf80 if it is sensitive to calcium-dependent signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that directly activates cAMP-dependent pathways. It can activate PKA, which may then phosphorylate and activate C11orf80 if it is a PKA substrate. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors, which can lead to increased cAMP levels and activation of PKA. This could result in the activation of C11orf80 if it is downstream of PKA signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can activate phospholipase C through its H1 receptor, leading to activation of the PKC pathway. If C11orf80 is a part of or regulated by the PKC signaling cascade, histamine could contribute to its activation. | ||||||